Role of natural products and intestinal flora on type 2 diabetes mellitus treatment

ArticleAçık Erişim

Özet

Diabetes mellitus (DM) is a complicated, globally expanding disease that is influenced by hereditary and environmental variables. Changes in modern society's food choices, physical inactivity, and obesity are significant factors in the development of type 2 DM (T2DM). The association between changes in intestinal flora and numerous disorders, including obesity, diabetes, and cardiovascular diseases, has been studied in recent years. The purpose of this review is to analyze the mechanisms underlying the alteration of the diabetic patients' intestinal flora, as well as their therapeutic choices. Also included is a summary of the antidiabetic benefits of natural compounds demonstrated by studies. The short-chain fatty acids theory, the bile acid theory, and the endotoxin theory are all potential methods by which intestinal flora contributes to the establishment and progression of T2DM. Due to an intestinal flora imbalance, abnormalities in shortchain fatty acids and secondary bile acids have been found in diabetic patients. Additionally, metabolic endotoxemia with altering flora induces a systemic inflammatory response by stimulating the immune system via bacterial translocation. The agenda for diabetes treatment includes the use of short-chain fatty acids, probiotics, prebiotics in the diet, fecal bacteria transplantation, and antibiotics. Animal studies have proven the antidiabetic benefits of numerous bioactive substances, including Flavonoids, Alkaloids, Saponin, and Allicin. However, further research is required to contribute to the treatment of diabetes © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12162Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.12998/wjcc.v11.i1.65Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAydin, Ozlem Celik
dc.contributor.authorAydın, Sonay
dc.contributor.authorBarun, Sureyya
dc.date.accessioned2026-10-18T20:27:05.973479191Z
dc.date.available2026-10-18T20:27:05.973479191Z
dc.date.issued2023
dc.description.abstractDiabetes mellitus (DM) is a complicated, globally expanding disease that is influenced by hereditary and environmental variables. Changes in modern society's food choices, physical inactivity, and obesity are significant factors in the development of type 2 DM (T2DM). The association between changes in intestinal flora and numerous disorders, including obesity, diabetes, and cardiovascular diseases, has been studied in recent years. The purpose of this review is to analyze the mechanisms underlying the alteration of the diabetic patients' intestinal flora, as well as their therapeutic choices. Also included is a summary of the antidiabetic benefits of natural compounds demonstrated by studies. The short-chain fatty acids theory, the bile acid theory, and the endotoxin theory are all potential methods by which intestinal flora contributes to the establishment and progression of T2DM. Due to an intestinal flora imbalance, abnormalities in shortchain fatty acids and secondary bile acids have been found in diabetic patients. Additionally, metabolic endotoxemia with altering flora induces a systemic inflammatory response by stimulating the immune system via bacterial translocation. The agenda for diabetes treatment includes the use of short-chain fatty acids, probiotics, prebiotics in the diet, fecal bacteria transplantation, and antibiotics. Animal studies have proven the antidiabetic benefits of numerous bioactive substances, including Flavonoids, Alkaloids, Saponin, and Allicin. However, further research is required to contribute to the treatment of diabetes © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
dc.identifier.doi10.12998/wjcc.v11.i1.65
dc.identifier.endpage72
dc.identifier.issn2307-8960
dc.identifier.issue1
dc.identifier.pmcidPMC9846977
dc.identifier.pmid36687192
dc.identifier.scopus2-s2.0-85146652971
dc.identifier.startpage65
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12162
dc.identifier.volume11
dc.identifier.wosWOS:000928071200007
dc.language.isoen
dc.publisherBaishideng Publishing Group Inc
dc.relation.ispartofWorld Journal of Clinical Cases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBioactive compounds
dc.subjectDiabetes mellitus
dc.subjectEndotoxemia
dc.subjectIntestinal flora
dc.subjectNatural products
dc.subjectProbiotics
dc.subjectalkaloid
dc.subjectallicin
dc.subjectanthocyanin
dc.subjectantibiotic agent
dc.subjectbile acid
dc.subjectcatechin
dc.subjectchenodeoxycholic acid
dc.subjectcholic acid
dc.subjectcytochrome P450
dc.subjectdeoxycholic acid
dc.subjectendotoxin
dc.subjectfarnesoid X receptor
dc.subjectflavanol derivative
dc.subjectflavonoid
dc.subjectglucagon like peptide 1
dc.subjectlithocholic acid
dc.subjectnatural product
dc.subjectprebiotic agent
dc.subjectprobiotic agent
dc.subjectsaponin
dc.subjectshort chain fatty acid
dc.subjecttoll like receptor 4
dc.subjectArticle
dc.subjectBacteroidetes
dc.titleRole of natural products and intestinal flora on type 2 diabetes mellitus treatment
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus15
rdl.citation.wos12
rdl.departmentDepartment of Medical Pharmacology, Erzincan Mengücek Gazi Training and Research Hospital, Erzincan 24100, Turkey. ozlemclk_89@hotmail.com. | Department of Radiology, Erzincan Binali Yıldırım University, Mengücek Gazi Training and Research Hospital, Erzincan 24100, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)